Taliani G, Rapicetta M, Francisci D, Xiang J, Sarrecchia B, De Bac C, Stagni G
Institute of Tropical Diseases, La Sapienza University, Rome, Italy.
Med Microbiol Immunol. 1991;180(5):239-48. doi: 10.1007/BF00202558.
The serum kinetics of preS1 and preS2 antigens has been evaluated in 38 serial samples from eight patients with chronic active (CAH) or chronic persistent (CPH) hepatitis, followed for 2-7 years (mean 4.4 years) in whom liver biopsy was performed at intervals, and in 46 samples from ten asymptomatic HBsAg carriers followed for 4-5 years (mean 4.6 years). Four patterns of preS behaviour have been observed: (1) persistently positive preS1 and preS2; (2) disappearance of preS2; (3) disappearance of both preS1 and preS2; and (4) persistently negative preS1 and preS2. Pattern 4 has been observed exclusively among healthy carriers, while seven out of eight chronic patients exhibited either pattern 1 or 2. Among the chronic patients, preS2 disappearance was accompanied or followed by alanine aminotransferase (ALT) normalization. The correlation of preS antigens with conventional viral replication markers showed that 100% of hepatitis B virus (HBV)-DNA-positive and 86.6% of HBeAg-positive sera were preS1/preS2 positive, while 61% of HBV-DNA-negative and 64% of HBeAg-negative sera were preS1/preS2 negative. Our data suggest that continuous monitoring of preS antigens in follow-up sera will allow for an improved prognostic evaluation of chronic HBV infection.
对8例慢性活动性(CAH)或慢性持续性(CPH)肝炎患者的38份系列血清样本进行了前S1和前S2抗原的血清动力学评估,这些患者随访了2至7年(平均4.4年),期间定期进行肝活检;还对10例无症状HBsAg携带者的46份样本进行了评估,随访了4至5年(平均4.6年)。观察到四种前S行为模式:(1)前S1和前S2持续阳性;(2)前S2消失;(3)前S1和前S2均消失;(4)前S1和前S2持续阴性。模式4仅在健康携带者中观察到,而8例慢性患者中有7例表现出模式1或2。在慢性患者中,前S2消失伴有或随后出现丙氨酸转氨酶(ALT)正常化。前S抗原与传统病毒复制标志物的相关性表明,100%的乙型肝炎病毒(HBV)DNA阳性血清和86.6%的HBeAg阳性血清前S1/前S2阳性,而61%的HBV DNA阴性血清和64%的HBeAg阴性血清前S1/前S2阴性。我们的数据表明,对随访血清中的前S抗原进行持续监测将有助于改善慢性HBV感染的预后评估。